Stress is a common occurrence in everyday life and repeated or traumatic stress can be a precipitating factor for illnesses of the central nervous system, as well as peripheral organ systems. For example, severe or long-term psychological stress can not only induce depression, a leading illness worldwide, but can also cause psychosomatic diseases such as asthma and rheumatoid arthritis. Related key questions include how psychological stress influences both brain and peripheral systems, and what detection mechanisms underlie these effects? A clue is provided by the discovery of the pathways underlying the responses to host ''danger'' substances that cause systemic diseases, but can also contribute to depression. The inflammasome is a protein complex that can detect diverse danger signals and produce the accompanying immune-inflammatory reactions. Interestingly, the inflammasome can detect not only pathogen-associated molecules, but also cell damage-associated molecules such as ATP. Here, we propose a new inflammasome hypothesis of depression and related comorbid systemic illnesses. According to this hypothesis, the inflammasome is a central mediator by which psychological and physical stressors can contribute to the development of depression, and as well as a bridge to systemic diseases. This hypothesis includes an explanation for how psychological stress can influence systemic diseases, and conversely how systemic diseases can lead to psychiatric illnesses. The evidence suggests that the inflammasome may be a new target for the development of treatments for depression, as well as psychosomatic and somatopsycho diseases.
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Introduction
Major depressive disorder (MDD) is characterized by depressed mood, low self-esteem, anhedonia, and disrupted sleeping, eating, and cognition, and has now been recognized to have an overall impact on global illness that is projected to be second only to ischemic heart disease in social and economical burden by 2020 (Greden, 2001; Murray and Lopez, 1997) . In the United States, about 14 million people, or about 10% of the population, suffer from depression at any point in time (Kessler et al., 2003) . Because approximately one third of MDD patients do not respond to traditional pharmacological medications such as monoamine reuptake inhibitors, there is a major unmet need for the development of novel, more efficacious therapeutic agents.
Although it is clear that genetic factors are involved [heritability estimates from twin studies are reported to be 37%-38% (Kendler et al., 2006; Sullivan et al., 2000) ], environmental factors such as stress are strongly implicated in the pathology of depression (Kessler, 1997) . Levels of stress have increased with growing social and economic demands in recent decades, resulting in a rapid rise in the prevalence of depression (Kessler et al., 2003) . Here, we discuss evidence that psychological, as well as physical stressors can activate immune and inflammation processes and lead to increased cytokine levels, contributing to structural and functional alterations of neurons and the development of MDD.
A role for inflammation and related cytokines in MDD was first suggested in the 1980's and since then evidence has accumulated in support of this hypothesis (Ader and Cohen, 1993; Maes, 1995; Maier et al., 1994; Tecoma and Huey, 1985) . There have been several excellent reviews of this work, but the current paper examines a novel aspect of the immune-inflammation process in the response to stress and depression: that interkeukin-1b (IL-1b) and its regulator, ''the Nod-like receptor (NLR) family, pyrin domaincontaining 3 (NLRP3) inflammasome'', are a bridge between psychological stress and depression. Related to this hypothesis is the possibility that the inflammasome provides a bidirectional pathway between depression and comorbid systemic illnesses, suggesting novel strategies for treating depression.
